Search Results - "Cundiff, Deborah L"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model by Hobbs, Jennifer E, Zakarija, Anaadriana, Cundiff, Deborah L, Doll, Jennifer A, Hymen, Emily, Cornwell, Mona, Crawford, Susan E, Liu, Na, Signaevsky, Maxim, Soff, Gerald A

    Published in Thrombosis research (2007)
    “…Abstract Introduction Tissue Factor (TF) expression is observed in many types of cancer, associated with more aggressive disease, and thrombosis…”
    Get full text
    Journal Article
  2. 2

    Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives by Sidney, Stephen, Petitti, Diana B, Soff, Gerald A, Cundiff, Deborah L, Tolan, Kimberly K, Quesenberry, Charles P

    Published in Contraception (Stoneham) (01-07-2004)
    “…To assess the relationship between venous thromboembolic disease (VTE) and use of low-estrogen dose (<50 μg) combined estrogen-progestin oral contraceptives…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface β-actin : Implications for cancer-mediated angiogenesis by HAO WANG, DOLL, Jennifer A, KEYI JIANG, CUNDIFF, Deborah L, CZARNECKI, Jarema S, WILSON, Mindy, RIDGE, Karen M, SOFF, Gerald A

    Published in Cancer research (Chicago, Ill.) (15-07-2006)
    “…Angiostatin4.5 (AS4.5) is the product of plasmin autoproteolysis and consists of kringles 1 to 4 and approximately 85% of kringle 5. In culture, cancer cell…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Cell surface-dependent generation of angiostatin4.5 by HAO WANG, SCHULTZ, Ryan, HONG, Jerome, CUNDIFF, Deborah L, KEYI JIANG, SOFF, Gerald A

    Published in Cancer research (Chicago, Ill.) (2004)
    “…Angiostatin4.5 (AS4.5) is a naturally occurring human angiostatin isoform, consisting of plasminogen kringles 1-4 plus 85% of kringle 5 (amino acids Lys78 to…”
    Get full text
    Journal Article
  8. 8

    Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin by GATELY, S, TWARDOWSKI, P, ENGHILD, J, KWAAN, H. C, SOFF, G. A, STACK, M. S, PATRICK, M, BOGGIO, L, CUNDIFF, D. L, SCHNAPER, H. W, MADISON, L, VOLPERT, O, BOUCK, N

    Published in Cancer research (Chicago, Ill.) (01-11-1996)
    “…Angiostatin is an inhibitor of angiogenesis and metastatic growth that is found in tumor-bearing animals and can be generated in vitro by the proteolytic…”
    Get full text
    Journal Article
  9. 9

    Expression of Alternatively-Spliced Human Tissue Factor, but Not Full-Length Tissue Factor, Enhances Tumor Growth and Tumor-Associated Vasculature by Soff, Gerald A., Hobbs, Jennifer, Hyman, Emily, Cundiff, Deborah L.

    Published in Blood (16-11-2006)
    “…It is well-established that cancer is associated with activation of the blood coagulation system, with associated thrombosis as a major cause of morbidity and…”
    Get full text
    Journal Article
  10. 10

    Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells by Hanford, Holly Anne, Wong, Christie A, Kassan, Hallie, Cundiff, Deborah L, Chandel, Navdeep, Underwood, Suzanne, Mitchell, Christopher A, Soff, Gerald A

    Published in Cancer research (Chicago, Ill.) (15-07-2003)
    “…Angiostatin, a proteolytic cleavage product of plasminogen, acts via a selective, yet poorly understood mechanism to potently inhibit angiogenesis (M. S…”
    Get full text
    Journal Article
  11. 11

    Differential Binding of Plasminogen, Plasmin, and Angiostatin4.5 to Cell Surface β-Actin: Implications for Cancer-Mediated Angiogenesis by Soff, Gerald A., Wang, Hao, Doll, Jennifer A., Jiang, Keyi, Cundiff, Deborah L.

    Published in Blood (16-11-2004)
    “…Angiostatin4.5 (AS4.5), the naturally occurring human angiostatin isoform, is the product of plasmin autoproteolysis and consists of kringles 1 to 4 and ~85%…”
    Get full text
    Journal Article
  12. 12

    Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP by Soff, G A, Cornwell, T L, Cundiff, D L, Gately, S, Lincoln, T M

    Published in The Journal of clinical investigation (15-11-1997)
    “…A key component of the nitric oxide-cyclic guanosine monophosphate (cGMP) pathway in smooth muscle cells (SMC) is the type I GMP-dependent protein kinase (PK-G…”
    Get full text
    Journal Article
  13. 13